Safety and Efficacy of Axicabtagene Ciloleucel versus Standard of Care in Patients 65 Years of Age or Older with Relapsed/Refractory Large B-Cell Lymphoma
在65岁及以上复发/难治性大B细胞淋巴瘤患者中,Axicabtagene Ciloleucel与标准治疗相比的安全性和有效性
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-3136
Westin, Jason R; Locke, Frederick L; Dickinson, Michael; Ghobadi, Armin; Elsawy, Mahmoud; van Meerten, Tom; Miklos, David B; Ulrickson, Matthew L; Perales, Miguel-Angel; Farooq, Umar; Wannesson, Luciano; Leslie, Lori; Kersten, Marie José; Jacobson, Caron A; Pagel, John M; Wulf, Gerald; Johnston, Patrick; Rapoport, Aaron P; Du, Linqiu; Vardhanabhuti, Saran; Filosto, Simone; Shah, Jina; Snider, Julia T; Cheng, Paul; To, Christina; Oluwole, Olalekan O; Sureda, Anna